Literature DB >> 439257

Extended pelvic lymphadenectomy for prostatic cancer.

M Golimbu, P Morales, S Al-Askari, J Brown.   

Abstract

Thirty patients with clinically localized prostatic carcinoma underwent extended pelvic lymph-adenectomy, including the presacral and presciatic (lateral sacral) areas. The first echelon of pelvic nodes to be involved by metastases was the external iliac, obturator, presacral and presciatic. The deep presacral-presciatic nodes were involved almost as often as the more superficial external iliac-obturator group. Metastases limited only to the deep pelvic nodes were found in 14 per cent of the cases.

Entities:  

Mesh:

Year:  1979        PMID: 439257     DOI: 10.1016/s0022-5347(17)56906-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer.

Authors:  Michal Staník; Ivo Čapák; Daniel Macík; Jiří Vašina; Eva Lžičařová; Jiří Jarkovský; Martin Šustr; David Miklánek; Jan Doležel
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

Review 2.  [The role of pelvic lymphadenectomy in clinically localised prostate cancer].

Authors:  M Schumacher; F C Burkhard; U E Studer
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 3.  Sentinel node evaluation in prostate cancer.

Authors:  Ramkishen Narayanan; Timothy G Wilson
Journal:  Clin Exp Metastasis       Date:  2018-09-05       Impact factor: 5.150

4.  The importance of pelvic lymph node dissection in men with clinically localized prostate cancer.

Authors:  Mohamad E Allaf; Alan W Partin; H Ballentine Carter
Journal:  Rev Urol       Date:  2006

5.  Therapeutic role of pelvic lymphadenectomy in carcinoma of the prostate: own experiences.

Authors:  P Morávek
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

6.  Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.

Authors:  Jarrod B Adkison; Derek R McHaffie; Søren M Bentzen; Rakesh R Patel; Deepak Khuntia; Daniel G Petereit; Theodore S Hong; Wolfgang Tomé; Mark A Ritter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

Review 7.  [Role of lymph node dissection in prostate cancer].

Authors:  T Schlomm; C Börgermann; H Heinzer; H Rübben; H Huland; M Graefen
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

8.  Incidence of lymph node involvement in localized carcinoma of the prostate.

Authors:  E K Reddy; W K Mebust; J W Weigel; S Giri; C M Mansfield
Journal:  J Natl Med Assoc       Date:  1984-05       Impact factor: 1.798

Review 9.  The role of lymphadenectomy in high risk prostate cancer.

Authors:  Fiona C Burkhard; Urs E Studer
Journal:  World J Urol       Date:  2008-03-28       Impact factor: 4.226

Review 10.  Nodal staging.

Authors:  Skandadas Ganeshalingam; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2009-12-24       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.